EBV
Clinical trials for EBV explained in plain language.
Never miss a new study
Get alerted when new EBV trials appear
Sign up with your email to follow new studies for EBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine trial aims to stop the virus that causes mono
⭐️ VACCINE ⭐️ Recruiting nowThis study tests two experimental vaccines designed to prevent Epstein-Barr virus (EBV) infection, which causes mono and is linked to certain cancers. About 750 healthy adults aged 18 to 29, both with and without prior EBV infection, will receive three doses of one or both vaccin…
Matched conditions: EBV
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:53 UTC
-
New drug combo aims to tame Epstein-Barr virus in chronic disease
Disease control Recruiting nowThis study tests whether combining two drugs, golidocitinib and selinexor, can control chronic active Epstein-Barr virus disease (CAEBVD). About 28 adults with active symptoms will receive the treatment. The goal is to reduce virus levels and improve disease activity.
Matched conditions: EBV
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Scientists hunt for hidden immune flaws behind severe virus cases
Knowledge-focused Recruiting nowThis study looks for immune system problems that might make some people get very sick from viruses like herpes, chickenpox, or HPV. Researchers will test blood and skin samples from up to 600 people who have had severe viral infections, along with their relatives. The goal is to …
Matched conditions: EBV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC